Selected research
Industry Growth & Trends
Global Exoglucanase Industry Growth and Trends Forecast to 2032
Market perspective
The global Exoglucanase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Exoglucanase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Exoglucanase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Exoglucanase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Exoglucanase include Mitsubishi Chemical, DuPont, BASF, Ultreze, Sunson Industry, Specialty Enzymes & Probiotics, Novozymes, KeyGene and Infinita Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Exoglucanase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Exoglucanase market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Exoglucanase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Exoglucanase.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Exoglucanase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Exoglucanase Market by Company
Mitsubishi Chemical
DuPont
BASF
Ultreze
Sunson Industry
Specialty Enzymes & Probiotics
Novozymes
KeyGene
Infinita Biotech
ENMEX
DuPont Industrial Biosciences
DSM
BIO-CAT
Amano Enzyme
AB Enzymes
Exoglucanase Segment by Type
Cutting to the Reduction End
Cutting to the Non-Reduction End
Exoglucanase Segment by Application
Food and Brewing Industry
Biomedical Material Synthesis
Lignocellulose Conversion
Extreme Environment Bioprocessing
Other
Exoglucanase Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exoglucanase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exoglucanase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exoglucanase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exoglucanase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Exoglucanase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cutting to the Reduction End
- Cutting to the Non-Reduction End
Applications
- Food and Brewing Industry
- Biomedical Material Synthesis
- Lignocellulose Conversion
- Extreme Environment Bioprocessing
- Other
Companies covered
- Mitsubishi Chemical
- DuPont
- BASF
- Ultreze
- Sunson Industry
- Specialty Enzymes & Probiotics
- Novozymes
- KeyGene
- Infinita Biotech
- ENMEX
- DuPont Industrial Biosciences
- DSM
- BIO-CAT
- Amano Enzyme
- AB Enzymes
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Exoglucanase Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Exoglucanase Sales Estimates and Forecasts (2021-2032)
- 1.3 Exoglucanase Market by Type
- 1.3.1 Cutting to the Reduction End
- 1.3.2 Cutting to the Non-Reduction End
- 1.4 Global Exoglucanase Market Size by Type
- 1.4.1 Global Exoglucanase Market Size Overview by Type (2021-2032)
- 1.4.2 Global Exoglucanase Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Exoglucanase Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Exoglucanase Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Exoglucanase Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Exoglucanase Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Exoglucanase Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Exoglucanase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Exoglucanase Industry Trends
- 2.2 Exoglucanase Industry Drivers
- 2.3 Exoglucanase Industry Opportunities and Challenges
- 2.4 Exoglucanase Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Exoglucanase Revenue (2021-2026)
- 3.2 Global Top Players by Exoglucanase Sales (2021-2026)
- 3.3 Global Top Players by Exoglucanase Price (2021-2026)
- 3.4 Global Exoglucanase Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Exoglucanase Major Company Production Sites & Headquarters
- 3.6 Global Exoglucanase Company, Product Type & Application
- 3.7 Global Exoglucanase Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Exoglucanase Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Exoglucanase Players Market Share by Revenue in 2025
- 3.8.3 2025 Exoglucanase Tier 1, Tier 2, and Tier 3
4 Exoglucanase Regional Status and Outlook
- 4.1 Global Exoglucanase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Exoglucanase Historic Market Size by Region
- 4.2.1 Global Exoglucanase Sales in Volume by Region (2021-2026)
- 4.2.2 Global Exoglucanase Sales in Value by Region (2021-2026)
- 4.2.3 Global Exoglucanase Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Exoglucanase Forecasted Market Size by Region
- 4.3.1 Global Exoglucanase Sales in Volume by Region (2027-2032)
- 4.3.2 Global Exoglucanase Sales in Value by Region (2027-2032)
- 4.3.3 Global Exoglucanase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Exoglucanase by Application
- 5.1 Exoglucanase Market by Application
- 5.1.1 Food and Brewing Industry
- 5.1.2 Biomedical Material Synthesis
- 5.1.3 Lignocellulose Conversion
- 5.1.4 Extreme Environment Bioprocessing
- 5.1.5 Other
- 5.2 Global Exoglucanase Market Size by Application
- 5.2.1 Global Exoglucanase Market Size Overview by Application (2021-2032)
- 5.2.2 Global Exoglucanase Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Exoglucanase Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Exoglucanase Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Exoglucanase Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Exoglucanase Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Exoglucanase Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Exoglucanase Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Mitsubishi Chemical
- 6.1.1 Mitsubishi Chemical Company Information
- 6.1.2 Mitsubishi Chemical Business Overview
- 6.1.3 Mitsubishi Chemical Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Mitsubishi Chemical Exoglucanase Product Portfolio
- 6.1.5 Mitsubishi Chemical Recent Developments
- 6.2 DuPont
- 6.2.1 DuPont Company Information
- 6.2.2 DuPont Business Overview
- 6.2.3 DuPont Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 DuPont Exoglucanase Product Portfolio
- 6.2.5 DuPont Recent Developments
- 6.3 BASF
- 6.3.1 BASF Company Information
- 6.3.2 BASF Business Overview
- 6.3.3 BASF Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 BASF Exoglucanase Product Portfolio
- 6.3.5 BASF Recent Developments
- 6.4 Ultreze
- 6.4.1 Ultreze Company Information
- 6.4.2 Ultreze Business Overview
- 6.4.3 Ultreze Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Ultreze Exoglucanase Product Portfolio
- 6.4.5 Ultreze Recent Developments
- 6.5 Sunson Industry
- 6.5.1 Sunson Industry Company Information
- 6.5.2 Sunson Industry Business Overview
- 6.5.3 Sunson Industry Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sunson Industry Exoglucanase Product Portfolio
- 6.5.5 Sunson Industry Recent Developments
- 6.6 Specialty Enzymes & Probiotics
- 6.6.1 Specialty Enzymes & Probiotics Company Information
- 6.6.2 Specialty Enzymes & Probiotics Business Overview
- 6.6.3 Specialty Enzymes & Probiotics Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Specialty Enzymes & Probiotics Exoglucanase Product Portfolio
- 6.6.5 Specialty Enzymes & Probiotics Recent Developments
- 6.7 Novozymes
- 6.7.1 Novozymes Company Information
- 6.7.2 Novozymes Business Overview
- 6.7.3 Novozymes Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Novozymes Exoglucanase Product Portfolio
- 6.7.5 Novozymes Recent Developments
- 6.8 KeyGene
- 6.8.1 KeyGene Company Information
- 6.8.2 KeyGene Business Overview
- 6.8.3 KeyGene Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 KeyGene Exoglucanase Product Portfolio
- 6.8.5 KeyGene Recent Developments
- 6.9 Infinita Biotech
- 6.9.1 Infinita Biotech Company Information
- 6.9.2 Infinita Biotech Business Overview
- 6.9.3 Infinita Biotech Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Infinita Biotech Exoglucanase Product Portfolio
- 6.9.5 Infinita Biotech Recent Developments
- 6.10 ENMEX
- 6.10.1 ENMEX Company Information
- 6.10.2 ENMEX Business Overview
- 6.10.3 ENMEX Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 ENMEX Exoglucanase Product Portfolio
- 6.10.5 ENMEX Recent Developments
- 6.11 DuPont Industrial Biosciences
- 6.11.1 DuPont Industrial Biosciences Company Information
- 6.11.2 DuPont Industrial Biosciences Business Overview
- 6.11.3 DuPont Industrial Biosciences Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 DuPont Industrial Biosciences Exoglucanase Product Portfolio
- 6.11.5 DuPont Industrial Biosciences Recent Developments
- 6.12 DSM
- 6.12.1 DSM Company Information
- 6.12.2 DSM Business Overview
- 6.12.3 DSM Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 DSM Exoglucanase Product Portfolio
- 6.12.5 DSM Recent Developments
- 6.13 BIO-CAT
- 6.13.1 BIO-CAT Company Information
- 6.13.2 BIO-CAT Business Overview
- 6.13.3 BIO-CAT Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 BIO-CAT Exoglucanase Product Portfolio
- 6.13.5 BIO-CAT Recent Developments
- 6.14 Amano Enzyme
- 6.14.1 Amano Enzyme Company Information
- 6.14.2 Amano Enzyme Business Overview
- 6.14.3 Amano Enzyme Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Amano Enzyme Exoglucanase Product Portfolio
- 6.14.5 Amano Enzyme Recent Developments
- 6.15 AB Enzymes
- 6.15.1 AB Enzymes Company Information
- 6.15.2 AB Enzymes Business Overview
- 6.15.3 AB Enzymes Exoglucanase Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 AB Enzymes Exoglucanase Product Portfolio
- 6.15.5 AB Enzymes Recent Developments
7 North America by Country
- 7.1 North America Exoglucanase Sales by Country
- 7.1.1 North America Exoglucanase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Exoglucanase Sales by Country (2021-2026)
- 7.1.3 North America Exoglucanase Sales Forecast by Country (2027-2032)
- 7.2 North America Exoglucanase Market Size by Country
- 7.2.1 North America Exoglucanase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Exoglucanase Market Size by Country (2021-2026)
- 7.2.3 North America Exoglucanase Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Exoglucanase Sales by Country
- 8.1.1 Europe Exoglucanase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Exoglucanase Sales by Country (2021-2026)
- 8.1.3 Europe Exoglucanase Sales Forecast by Country (2027-2032)
- 8.2 Europe Exoglucanase Market Size by Country
- 8.2.1 Europe Exoglucanase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Exoglucanase Market Size by Country (2021-2026)
- 8.2.3 Europe Exoglucanase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Exoglucanase Sales by Country
- 9.1.1 Asia-Pacific Exoglucanase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Exoglucanase Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Exoglucanase Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Exoglucanase Market Size by Country
- 9.2.1 Asia-Pacific Exoglucanase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Exoglucanase Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Exoglucanase Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Exoglucanase Sales by Country
- 10.1.1 South America Exoglucanase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Exoglucanase Sales by Country (2021-2026)
- 10.1.3 South America Exoglucanase Sales Forecast by Country (2027-2032)
- 10.2 South America Exoglucanase Market Size by Country
- 10.2.1 South America Exoglucanase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Exoglucanase Market Size by Country (2021-2026)
- 10.2.3 South America Exoglucanase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Exoglucanase Sales by Country
- 11.1.1 Middle East and Africa Exoglucanase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Exoglucanase Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Exoglucanase Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Exoglucanase Market Size by Country
- 11.2.1 Middle East and Africa Exoglucanase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Exoglucanase Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Exoglucanase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Exoglucanase Value Chain Analysis
- 12.1.1 Exoglucanase Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Exoglucanase Production Mode & Process
- 12.2 Exoglucanase Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Exoglucanase Distributors
- 12.2.3 Exoglucanase Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst